Table 1.
Baseline clinical characteristics of the intervention and control groups before resveratrol or placebo supplementation.
| Control group | Intervention group | P value | |
|---|---|---|---|
| Age (yrs) | 51.81 ± 6.99 | 52.45 ± 6.18 | 0.697 |
| Sex (female/male) | 16/17 | 17/16 | 0.806 |
| Duration of disease (yrs) | 5.39 ± 1.36 | 5.81 ± 1.53 | 0.239 |
| Family history of diabetes (yrs) | 24 (77.4%) | 15 (50.0%) | 0.024* |
| Smoking (n) | 4 (12.9%) | 7 (21.90%) | 0.348 |
| History of hypertension (n) | 8 (27.6%) | 9 (29.0%) | 0.901 |
Data is presented as means ± SD. For history of diabetes, smoking, and hypertension, the bracketed value corresponds to the total percentage of participants in respective groups. *P < 0.05 versus control group.